NCT03678350View on ClinicalTrials.gov

Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 17, 2021

Primary Completion Date

November 13, 2023

Study Completion Date

October 13, 2026

Conditions
Malignant MesotheliomaNon-Small Cell Lung CarcinomaPleural Disorder
Interventions
DEVICE

Light Dosimetry for Intranoperative Therapy

Undergo IO-PDT

PROCEDURE

Photodynamic Therapy

Undergo IO-PDT

DRUG

Porfimer Sodium

Given IV

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

Sponsors

Collaborators (1)

Lumeda,Inc.
All Listed Sponsors
collaborator

Lumeda,Inc.

UNKNOWN

lead

Roswell Park Cancer Institute

OTHER